MIDLAND EXPLORATION INC (MD.CA) Stock Fundamental Analysis

TSX-V:MD • CA59751U1003

0.52 CAD
0 (0%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall MD gets a fundamental rating of 2 out of 10. We evaluated MD against 816 industry peers in the Metals & Mining industry. MD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • MD had negative earnings in the past year.
  • MD had a negative operating cash flow in the past year.
  • In the past 5 years MD always reported negative net income.
  • MD had a negative operating cash flow in each of the past 5 years.
MD.CA Yearly Net Income VS EBIT VS OCF VS FCFMD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M

1.2 Ratios

  • MD's Return On Assets of -4.54% is fine compared to the rest of the industry. MD outperforms 72.68% of its industry peers.
  • MD has a better Return On Equity (-4.77%) than 74.78% of its industry peers.
Industry RankSector Rank
ROA -4.54%
ROE -4.77%
ROIC N/A
ROA(3y)-3.98%
ROA(5y)-3.87%
ROE(3y)-4.17%
ROE(5y)-4.03%
ROIC(3y)N/A
ROIC(5y)N/A
MD.CA Yearly ROA, ROE, ROICMD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1 -2 -3 -4

1.3 Margins

  • MD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MD.CA Yearly Profit, Operating, Gross MarginsMD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • MD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MD has more shares outstanding
  • The number of shares outstanding for MD has been increased compared to 5 years ago.
  • The debt/assets ratio for MD is higher compared to a year ago.
MD.CA Yearly Shares OutstandingMD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
MD.CA Yearly Total Debt VS Total AssetsMD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • An Altman-Z score of 14.88 indicates that MD is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of MD (14.88) is better than 65.88% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that MD is not too dependend on debt financing.
  • The Debt to Equity ratio of MD (0.01) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 14.88
ROIC/WACCN/A
WACC10.55%
MD.CA Yearly LT Debt VS Equity VS FCFMD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 4.55 indicates that MD has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 4.55, MD is doing good in the industry, outperforming 69.72% of the companies in the same industry.
  • A Quick Ratio of 4.55 indicates that MD has no problem at all paying its short term obligations.
  • The Quick ratio of MD (4.55) is better than 70.46% of its industry peers.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 4.55
MD.CA Yearly Current Assets VS Current LiabilitesMD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 3.08% over the past year.
  • MD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.64%.
  • Measured over the past years, MD shows a very strong growth in Revenue. The Revenue has been growing by 47.20% on average per year.
EPS 1Y (TTM)3.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-650%
Revenue 1Y (TTM)-15.64%
Revenue growth 3Y-7.88%
Revenue growth 5Y47.2%
Sales Q2Q%19.31%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MD.CA Yearly Revenue VS EstimatesMD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100K 200K 300K

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • MD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MD.CA Price Earnings VS Forward Price EarningsMD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MD.CA Per share dataMD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MIDLAND EXPLORATION INC

TSX-V:MD (2/27/2026, 7:00:00 PM)

0.52

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners16.7%
Inst Owner ChangeN/A
Ins Owners4.19%
Ins Owner ChangeN/A
Market Cap58.74M
Revenue(TTM)164.50K
Net Income(TTM)-2.12M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 357.11
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB 1.32
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.39
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.54%
ROE -4.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.98%
ROA(5y)-3.87%
ROE(3y)-4.17%
ROE(5y)-4.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11090.2%
Cap/Sales 2002.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 4.55
Altman-Z 14.88
F-Score2
WACC10.55%
ROIC/WACCN/A
Cap/Depr(3y)11608%
Cap/Depr(5y)13524.1%
Cap/Sales(3y)1608.82%
Cap/Sales(5y)1919.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-650%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.64%
Revenue growth 3Y-7.88%
Revenue growth 5Y47.2%
Sales Q2Q%19.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.22%
OCF growth 3YN/A
OCF growth 5YN/A

MIDLAND EXPLORATION INC / MD.CA FAQ

What is the ChartMill fundamental rating of MIDLAND EXPLORATION INC (MD.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MD.CA.


What is the valuation status for MD stock?

ChartMill assigns a valuation rating of 0 / 10 to MIDLAND EXPLORATION INC (MD.CA). This can be considered as Overvalued.


How profitable is MIDLAND EXPLORATION INC (MD.CA) stock?

MIDLAND EXPLORATION INC (MD.CA) has a profitability rating of 1 / 10.